GWS
BMY icon

Greykasell Wealth Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Greykasell Wealth Strategies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Hold
1,848
– – 0.04% 186
2026
Q1 		$112K Buy
1,848
+214
+13% +$12.5K 0.05% 182
2025
Q4 		$88.1K Sell
1,634
-115
-7% -$5.53K 0.03% 196
2025
Q3 		$78.9K Hold
1,749
– – 0.03% 184
2025
Q2 		$80.9K Sell
1,749
-163
-9% -$8K 0.04% 170
2025
Q1 		$117K Buy
+1,912
New +$111K 0.06% 143

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Greykasell Wealth Strategies's BMY Position: Q2 2026 in Review

Greykasell Wealth Strategies held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,848 shares worth $106K. The position accounts for 0.04% of the portfolio, ranked #186.

Greykasell Wealth Strategies first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $117K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Greykasell Wealth Strategies held 1,848 shares of Bristol-Myers Squibb worth $106K as of Q2 2026.
  • Greykasell Wealth Strategies left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.04% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #186 holding.
  • Greykasell Wealth Strategies first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • Greykasell Wealth Strategies's Bristol-Myers Squibb position peaked at $117K in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.